In The News

Chugai investing S$476m more into S'pore facility

SingaporeJAPANESE drug maker Chugai Pharmaceutical on Wednesday announced that it will invest S$476 million from now until 2021 into its research institute in Singapore, Chugai Pharmabody Research (CPR).When CPR first set up its corporate laboratory here in 2012 to develop antibody drugs, it planned to pour about S$200 million into antibody research over the subsequent five years.The new grant...


Drug giant to expand Singapore R&D unit

JAPAN'S Chugai Pharmaceutical will invest $476 million over the next seven years to expand its research institute here. The investment will make the centre at Biopolis one of the biggest pharmaceutical research and development operations in Singapore. It will also "significantly boost the company's local employee base and antibody research and development pipeline", said Chugai Pharmaceutical,...


S'pore team develops blood test for cancers

SINGAPOREANS could soon test whether they have breast or gastric cancer just by giving a few drops of blood. Scientists here have developed a blood test which takes just three hours and can detect even the early stages of the cancers, before symptoms start to appear. They achieved more than 90 per cent accuracy in laboratory tests, and plan to work with hospitals here to introduce the blood test...


More news...

Events |

More
 

BioPharma Asia Convention 2015

The BioPharma Asia Convention is the leading industry platform for pharmas, biotechs, CMOs, CROs and investors to assemble and assess the latest trends, source for new partnerships as well shop for new solutions and technology. Taking place in Singapore, 23-26 March 2015
 

Medical Fair Thailand 2015

Thailand No 1 medical & healthcare event, focused on equipment and supplies for the hospital, diagnostic, pharmaceutical, medical & rehabilitation sectors.
More events...